Prescribing overview
Potassium-sparing aldosterone antagonist used in veterinary cardiac care.
Canine Stage C heart-failure adjunct supported by consensus; feline pilot evidence is limited.
Key prescribing checks
- Assess renal function and potassium.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Pharmacology & pharmacokinetics
Mechanism and clinical role
Blocks aldosterone receptors and promotes potassium retention.
Absorption, distribution, metabolism and elimination
Active metabolites contribute activity; canine absorption is food sensitive.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Aldactone
Reviewed product labeling; human restrictions require veterinary interpretation unless an animal label is specified.
Contraindications · when not to use
- Human label: hyperkalemia, Addison disease or concurrent eplerenone.
Precautions & monitoring
- Hypotension, renal deterioration and electrolyte abnormalities.
Species status describes the reviewed evidence, not permission to self-prescribe.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Electrolyte disturbances, renal changes and gastrointestinal intolerance.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
Veterinarian selects the individual regimen; no human doses are transferred to animals.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Aldactone
Reviewed product labeling; human restrictions require veterinary interpretation unless an animal label is specified.
- ACE inhibitors/ARBs and potassium products increase hyperkalemia risk; NSAIDs may impair renal safety and response.
Monitoring
Potassium, renal function, hydration and blood pressure.
Client counseling
Report weakness, collapse or poor appetite; disclose potassium supplements.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the dispensed container; protect from children and accidental animal ingestion.
Brands, formulations & ingredient identity
Active ingredients
Spironolactone
Aldactone is single ingredient; Cardalis also contains benazepril and is a separate combination.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Aldactone
- Formulation
- Oral tablets
- Label / product scope
- Human product
Veterinary use is extra-label.
Product label / source ↗References & review status
Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
